oleic acid and Coronary Restenosis

oleic acid has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abendschein, DR; Chinen, LK; Fuhrhop, RW; Karukstis, KK; Lanza, GM; Scherrer, DE; Scott, MJ; Wickline, SA; Winter, PM; Yu, X	1

Other Studies

1 other study(ies) available for oleic acid and Coronary Restenosis

Article	Year
Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation, 2002, Nov-26, Volume: 106, Issue:22 Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Cell Count; Cell Division; Cell Membrane; Cells, Cultured; Contrast Media; Coronary Restenosis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fluorine Compounds; Fluorocarbons; Gadolinium DTPA; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Muscle, Smooth, Vascular; Oleic Acid; Oleic Acids; Paclitaxel; Particle Size; Swine; Thromboplastin	2002

Article

Year

Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.

Circulation, 2002, Nov-26, Volume: 106, Issue:22

Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Cell Count; Cell Division; Cell Membrane; Cells, Cultured; Contrast Media; Coronary Restenosis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fluorine Compounds; Fluorocarbons; Gadolinium DTPA; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Muscle, Smooth, Vascular; Oleic Acid; Oleic Acids; Paclitaxel; Particle Size; Swine; Thromboplastin

2002